SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 38.56 |
| Enterprise Value ($M) | 245.86 |
| Book Value ($M) | -205.88 |
| Book Value / Share | -24.03 |
| Price / Book | -0.19 |
| NCAV ($M) | -228.07 |
| NCAV / Share | -26.62 |
| Price / NCAV | -0.17 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.79 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.11 |
| Current Ratio | 1.17 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 105.52 |
| Assets | 127.71 |
| Liabilities | 333.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 145.24 |
| Operating Income | -119.44 |
| Net Income | -76.42 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -127.49 |
| Cash from Investing | 95.47 |
| Cash from Financing | 41.65 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Affinity Asset Advisors, LLC | 7.83 | ||
| 13G | Adage Capital Management, L.P. | 5.18 | ||
| 13G/A | Avidity Partners Management LP | 3.70 | -57.63 | |
| 13G/A | Vanguard Group Inc | 6.13 | 0.00 | |
| 13G | Highbridge Capital Management Llc | 7.20 | ||
| 13G/A | BlackRock, Inc. | 3.50 | -58.60 | |
| 13G | J. Wood Capital Advisors Llc | 5.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 48,736 | 138,070 | 35.30 | |
| 16,481 | 54,076 | 30.48 | |
| 43,705 | 115,480 | 37.85 | |
| 18,749 | 82,325 | 22.77 | |
| 23,064 | 108,456 | 21.27 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| JAZZ – Jazz Pharmaceuticals plc | KMDA – Kamada Ltd. |
| KNSA – Kiniksa Pharmaceuticals, Ltd. | KRYS – Krystal Biotech, Inc. |
| KURA – Kura Oncology, Inc. |
Financial data and stock pages provided by
Fintel.io